These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23558314)

  • 1. Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain.
    Kakkar V; Mishra AK; Chuttani K; Kaur IP
    Int J Pharm; 2013 May; 448(2):354-9. PubMed ID: 23558314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.
    Kakkar V; Muppu SK; Chopra K; Kaur IP
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):339-45. PubMed ID: 23454202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood.
    Kumar M; Kakkar V; Mishra AK; Chuttani K; Kaur IP
    Int J Pharm; 2014 Jan; 461(1-2):223-33. PubMed ID: 24286922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of radiolabeled curcumin-loaded solid lipid nanoparticles usage as an imaging agent in liver-spleen scintigraphy.
    Ayan AK; Yenilmez A; Eroglu H
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():663-670. PubMed ID: 28415513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression.
    He X; Zhu Y; Wang M; Jing G; Zhu R; Wang S
    Int J Nanomedicine; 2016; 11():4975-4990. PubMed ID: 27757031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study.
    Kakkar V; Kaur IP; Kaur AP; Saini K; Singh KK
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1701-1712. PubMed ID: 29938544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation.
    Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
    Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.
    Ramalingam P; Ko YT
    Pharm Res; 2015 Feb; 32(2):389-402. PubMed ID: 25082210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats.
    Kakkar V; Singh S; Singla D; Sahwney S; Chauhan AS; Singh G; Kaur IP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3427-31. PubMed ID: 21111692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability.
    Wang W; Zhao X; Hu H; Chen D; Gu J; Deng Y; Sun J
    Drug Deliv; 2010 Apr; 17(3):114-22. PubMed ID: 20148709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
    Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K
    J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin.
    Wang T; Ma X; Lei Y; Luo Y
    Colloids Surf B Biointerfaces; 2016 Dec; 148():1-11. PubMed ID: 27588376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.
    Ban C; Jo M; Park YH; Kim JH; Han JY; Lee KW; Kweon DH; Choi YJ
    Food Chem; 2020 Jan; 302():125328. PubMed ID: 31404868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration.
    Ren J; Zou M; Gao P; Wang Y; Cheng G
    Eur J Pharm Biopharm; 2013 Feb; 83(2):141-8. PubMed ID: 23201052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Drug Target; 2006 Nov; 14(9):632-45. PubMed ID: 17090399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nose-to-brain delivery of tacrine.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.